NCT06660381View on ClinicalTrials.gov

Psilocybin-assisted Treatment for Cannabis Use Disorder

PHASE1RecruitingINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

November 8, 2024

Primary Completion Date

March 31, 2026

Study Completion Date

September 30, 2026

Conditions
Cannabis Use Disorder
Interventions
DRUG

Psilocybin

Participants will receive a moderately high dose (25mg) of psilocybin in week 5 of the 12-week counseling, and either another moderately high dose (25mg) or a high dose (35mg) in week 7.

Trial Locations (1)

21224

RECRUITING

Johns Hopkins Center for Psychedelic and Consciousness Research, Baltimore

All Listed Sponsors
collaborator

Center for Psychedelic and Consciousness Research

UNKNOWN

lead

Johns Hopkins University

OTHER